A Case Report on Acute Hypersensitivity Reaction to Metronidazole Injection in a Female patient
Keywords:
N\AAbstract
This case report discusses a 75-year-old female patient with a history of varicose veins, hypertension, and stroke, who presented with pain, swelling, and discharge from the left leg, ultimately diagnosed with bilateral lower limb lymphedema and lymphangitis. The patient experienced an acute hypersensitivity reaction after the administration of intravenous metronidazole, characterized by facial urticaria. The mechanism of this Type I hypersensitivity reaction involves sensitization to metronidazole, leading to IgE-mediated mast cell degranulation upon re-exposure. Given the patient's allergic reaction, clindamycin was identified as a safe alternative antibiotic, effective against anaerobic infections and Gram-positive cocci. This case underscores the importance of vigilance for drug-induced hypersensitivity reactions, particularly in older patients with multiple comorbidities, and highlights the necessity for careful monitoring and personalized antibiotic therapy to ensure patient safety.
Downloads
References
This case report discusses a 75-year-old female patient with a history of varicose veins, hypertension, and stroke, who presented with pain, swelling, and discharge from the left leg, ultimately diagnosed with bilateral lower limb lymphedema and lymphangitis. The patient experienced an acute hypersensitivity reaction after the administration of intravenous metronidazole, characterized by facial urticaria. The mechanism of this Type I hypersensitivity reaction involves sensitization to metronidazole, leading to IgE-mediated mast cell degranulation upon re-exposure. Given the patient's allergic reaction, clindamycin was identified as a safe alternative antibiotic, effective against anaerobic infections and Gram-positive cocci. This case underscores the importance of vigilance for drug-induced hypersensitivity reactions, particularly in older patients with multiple comorbidities, and highlights the necessity for careful monitoring and personalized antibiotic therapy to ensure patient safety.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
